NPR News: BioNTech CEO Says 'Highly Likely' Vaccine Is Effective Against U.K. Virus Variant

BioNTech CEO Says 'Highly Likely' Vaccine Is Effective Against U.K. Virus Variant
"Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variant," BioNTech CEO Ugur Sahin said Tuesday.

Read more on NPR